Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

ETONETON

Showing 5 of 9 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in Eton Pharmaceuticals, Inc.

No. Qube Research & Technologies exited its ETON (Eton Pharmaceuticals) position in Q3 2025. Its Q2 2025 13F listed 34,557 shares worth $492,437. Qube Research & Technologies first reported ETON in Q3 2023 and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$194,052

Total Shares Change

-32,342

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$21.73
0
2025-Q2
Decreased
34,557
-60.2%
$492,4370.0%$14.25
0
2025-Q1
Decreased
86,848
-7.8%
$1.1M0.0%$12.98
0
2024-Q4
Increased
94,181
+191.2%
$1.3M0.0%$13.32
41
2024-Q3
Increased
32,342
+8085x
$194,0520.0%$6.00
37

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used